VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemesNewsEarningsCompareWatchlistInsider
ICCMIceCure Medical Ltd$0.1517$10M
Research
Overview
Valuation
ValuationTargetsPrice
Financials
RevenueEarningsP/ERatiosDividend
Ownership
Holders
Tools
Total ReturnDCA Calculator
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

Follow VCP Scanner on LinkedIn
© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
HomeStocksICCMEarnings History

ICCM logoIceCure Medical Ltd (ICCM) Earnings History

Net Loss

12 years of earnings data (2014–2025) · Currently unprofitable on a TTM basis

TTM Net Income
-$16M
● Net Loss
TTM EPS (Diluted)
$-0.21
Per share, diluted
YoY EPS Growth
+20.0%
Excellent
Net Margin
-445.6%
After-tax profitability
EPS Growth Rate (CAGR)
1YN/A
3YN/A
5YN/A
10YN/A
Operating Margin-446.7%
Gross Margin36.3%
Return on Equity-188.8%
Return on Assets-113.8%
Record Annual Net Income-$3MFY2017
Record Quarterly EPS$-0.03Q4 2020
Consecutive Profitable Years0years
Q1 2026
Net Income-$4M
EPS (Diluted)$-0.06
YoY Growth+20.0%Excellent
QoQ Growth-0.7%Slow

Loading earnings history...

IceCure Medical Ltd (ICCM) Earnings Overview

As of June 4, 2026, IceCure Medical Ltd (ICCM) reported trailing twelve-month net income of -$16M, reflecting +20.0% year-over-year growth. The company earned $-0.21 per diluted share over the past four quarters, with a net profit margin of -445.6%.

Looking at the long-term picture, ICCM's historical earnings data spans multiple years. The company achieved its highest annual net income of -$3M in fiscal 2017.

IceCure Medical Ltd is currently reporting a net loss, though operating performance should be evaluated in the context of growth investments and industry dynamics View revenue history →

Compared to peers including NVCR (-$173M net income, -20.8% margin), XTNT ($2M net income, 3.7% margin), ATEC (-$125M net income, -18.8% margin), ICCM has room to improve margins relative to the peer group. Compare ICCM vs NVCR →

ICCM Earnings vs Peers

Earnings metrics vs comparable public companies

CompanyTTM Net IncomeTTM EPSNet MarginROEYoY GrowthCompare
ICCM logoICCMCurrent
-$16M$-0.21-445.6%-188.8%+20.0%—
NVCR logoNVCR
-$173M$-1.52-20.8%-38.9%+21.8%
XTNT logoXTNT
$2M$0.013.7%10.6%+125.0%
ATEC logoATEC
-$125M$-0.81-18.8%-630.7%+15.0%
HALO logoHALO
$349M$2.8422.7%153.6%-25.4%
ISRG logoISRG
$3.0B$8.2828.4%16.6%+22.6%
Best in group
Lowest in group

ICCM Historical Earnings Data (2014–2025)

12 years
Fiscal Year Net Income YoY % Operating Income EPS (Diluted) Net Margin Op. Margin
2025-$15M+1.7%-$15M$-0.24-445.6%-446.7%
2024-$15M-4.5%-$16M$-0.30-465.5%-476.9%
2023-$15M+14.9%-$16M$-0.32-453.8%-482.4%
2022-$17M-71.0%-$17M$-0.47-558.1%-542.6%
2021-$10M-110.7%-$10M$-0.35-243.3%-235.0%
2020-$5M-0.4%-$4M$-0.28-117.0%-106.8%
2019-$5M-34.7%-$5M$-0.35-287.2%-278.0%
2018-$4M-22.9%-$3M$-0.30-329.7%-295.8%
2017-$3M+12.1%-$3M$-0.46-417.2%-386.6%
2016-$3M+12.8%-$3M$-0.62-522.8%-496.2%
2015-$4M+20.4%-$4M$-1.15-491.8%-462.6%
2014-$5M--$4M$-3.69-441.1%-383.3%

Download Data

Export ICCM earnings history in CSV or JSON format

Free sign-in required to download data

What if you invested $1,000 in ICCM back in 2014?

Total return with dividends reinvested · 12+ years of data

Calculate Returns

How much would $100/month in ICCM be worth today?

Dollar cost averaging vs lump sum · see how regular investing compounds over time

Run the Numbers

Is ICCM Undervalued Right Now?

DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.

View Valuation

ICCM vs DBVT — which is the better buy?

Side-by-side revenue, margins, P/E and 10-year returns vs DBV Technologies S.A..

Compare Now

ICCM — Frequently Asked Questions

Quick answers to the most common questions about buying ICCM stock.

What is ICCM earnings per share (EPS)?

ICCM trailing twelve-month (TTM) diluted EPS is $-0.21, reflecting +20.0% year-over-year growth. The 5-year EPS CAGR is N/A. Complete EPS history from 2014 to 2025 is available in the table on this page.

What is IceCure Medical Ltd's net income?

IceCure Medical Ltd (ICCM) trailing twelve-month net income is $-16M as of 2025. Earnings grew +20.0% year-over-year.

Is ICCM profitable?

ICCM is not currently profitable on a TTM basis, reporting a net loss of $-16M. Net margin is -445.6%. Investors should monitor for a return to profitability.

What is ICCM's earnings growth rate?

ICCM compound annual EPS growth rates (CAGR): 1-Year: N/A, 3-Year: N/A, 5-Year: N/A, 10-Year: N/A. These figures measure the annualised rate of diluted EPS growth over each period, based on data from 2014 to 2025.

What are ICCM's profit margins?

IceCure Medical Ltd net profit margin is -445.6%, operating margin is -446.7%, and gross margin is +36.3%. Below-average margins reflect competitive or cost pressures. Return on Equity is -188.8%.

Is ICCM growing earnings?

Yes, ICCM earnings are accelerating — EPS growth of +20.0% exceeds the 5-year CAGR of N/A. TTM net income reached $-16M. Earnings momentum is strengthening.

What was ICCM's best earnings year?

IceCure Medical Ltd's highest annual net income on record is $-3M, achieved in fiscal year 2017. Earnings history on this page spans 2014 to 2025 and includes all annual and quarterly figures.

What were ICCM's earnings last quarter?

ICCM's most recent reported quarter was Q1 2026. Net income was $-4M with diluted EPS of $-0.06. For a full breakdown of all quarters, see the quarterly earnings table on this page.

ICCM Earnings Over Time (2014–2025)

Net income & EPS — annual and quarterly view